Beta Bionics, Inc. (BBNX) vs Gyre Therapeutics, Inc. (GYRE)
A side-by-side comparison of Beta Bionics, Inc. and Gyre Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBNX
Beta Bionics, Inc.
$18.98HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
GYRE
Gyre Therapeutics, Inc.
$7.25HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — BBNX vs GYRE
growth of $100 · dividends reinvested · last 2yBBNX -19.8% (-10.4%/yr)GYRE -37.4% (-20.9%/yr)BBNX compounded faster over this window
BBNX GYRE
BBNX vs GYRE: by the numbers
- •BBNX is the larger company ($854M vs $808M market cap).
- •Both run net losses; GYRE's is the smaller (-14.52% vs -61.32% net margin).
Metrics side by side
Valuation
| Metric | BBNX | GYRE |
|---|---|---|
| P/S ratio | 7.17 | 6.77 |
| P/B ratio | 3.33 | 7.49 |
Profitability
| Metric | BBNX | GYRE |
|---|---|---|
| Gross margin | 58.31% | 94.30% |
| Operating margin | -69.75% | 9.86% |
| Net margin | -61.32% | -14.52% |
| ROE | -28.46% | -13.30% |
| ROIC | -31.17% | -9.77% |
Growth (annualized)
| Metric | BBNX | GYRE |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 84.92% |
| Total return CAGR (5Y) | N/A | -0.34% |
Go deeper
Dig into the metrics
Beta Bionics ROEGyre Therapeutics ROEBeta Bionics operating marginGyre Therapeutics operating marginBeta Bionics revenue growthGyre Therapeutics revenue growthBeta Bionics free cash flowGyre Therapeutics free cash flow
Beta Bionics & Gyre Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.